Nanobiotix【NBTX】銘柄情報

Nanobiotix SA (NBTX) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

35.54

( 0.59% )

買値

29.00

売値

41.00

出来高

84,279

33.51 日の範囲 35.99

4.18 52 週間の範囲 57.14

時価総額

1.802B

前日終値

35.33

始値

33.51

時刻

35.54

最終取引時間

財務取引量

US$ 2,945,147

VWAP

34.9452

平均取引量 (3 か月)

US$ 272,415

発行済株式数

50,713,979

配当利回り

PER

-61.79

1 株当たり利益 (EPS)

-0.5

歳入

32.59M

純利益

-23.96M

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of ... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.nanobiotix.com

本社

Paris, France

設立

2026

Nanobiotix SA is listed in the Healthcare sector of the ナスダック市場 with ticker NBTX. The last closing price for Nanobiotix was US$35.33. Over the last year, Nanobiotix shares have traded in a share price range of US$ 4.18 to US$ 57.14.

Nanobiotix currently has 50,713,979 shares in issue. The market capitalisation of Nanobiotix is US$1.80 billion. Nanobiotix has a price to earnings ratio (PE ratio) of -61.79.

Voting Rights and Shares Capital of the Company

PARIS, June 05, 2026 (GLOBE NEWSWIRE) -- Market: Euronext Paris / NasdaqEuronext Compartment: B ISIN code:...

Nanobiotix Provides First Quarter 2026 Operational and Financial Update

Completed a follow-on offering in May 2026 for aggregate gross proceeds of approximately €86.1 million...

Nanobiotix Joins the Euronext Tech Leaders Index

PARIS and CAMBRIDGE, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the...

NANOBIOTIX Announces Closing of Global Offering

PARIS and CAMBRIDGE, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX –...

NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million

PARIS and CAMBRIDGE, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX –...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.86	-2.36263736264	36.4	36.47	31.68	69402	34.68013907	DR
4	-16.75	-32.0328934787	52.29	53.9505	31.68	60220	39.89476409	DR
12	4.99	16.3338788871	30.55	57.14	28.395	77105	37.19164836	DR
26	12.26	52.6632302405	23.28	57.14	19.61	56425	33.72853234	DR
52	30.28	575.66539924	5.26	57.14	4.18	56065	26.21453674	DR
156	30.43	595.499021526	5.11	57.14	2.76	36511	16.59719154	DR
260	19.54	122.125	16	57.14	1.75	57958	10.35414282	DR